AGXT2 and metabolic dysfunction-associated steatotic liver disease: Low expression of Agxt2 leads to insufficient glycine biosynthesis [51], imbalance of antioxidant and oxidative status of the liver, resulting in hepatic lipid deposition-induced endoplasmic reticulum stress, and exacerbating fibrotic changes in NAFLD mice [52].